Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Tosif, S, Neeland, MR, Sutton, P, Licciardi, PV, Sarkar, S, Selva, KJ, Do, LAH, Donato, C, Quan Toh, Z, Higgins, R, et al.
Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19..
Nat Commun
11(1)
:
5703
2020
view publication
Stock, SJ, Brockway, M, Zoega, H, Been, JV, Sheikh, A, Bhutta, ZA, Burgner, DP, Azad, MB.
Enabling a healthy start for vulnerable newborns..
Lancet
396(10261)
:
1490
2020
view publication
Strunk, T, van Haren, SD, Hibbert, J, Pettengill, M, Ozonoff, A, Jans, J, Schüller, SS, Burgner, D, Levy, O, Currie, AJ.
Cyclic AMP in human preterm infant blood is associated with increased TLR-mediated production of acute-phase and anti-inflammatory cytokines in vitro..
Pediatr Res
88(5)
:
717 -725
2020
view publication
Miller, JE, Goldacre, R, Moore, HC, Zeltzer, J, Knight, M, Morris, C, Nowell, S, Wood, R, Carter, KW, Fathima, P, et al.
Mode of birth and risk of infection-related hospitalisation in childhood: A population cohort study of 7.17 million births from 4 high-income countries..
PLoS Med
17(11)
:
e1003429
2020
view publication
Laitinen, TT, Nuotio, J, Niinikoski, H, Juonala, M, Rovio, SP, Viikari, JSA, Rönnemaa, T, Magnussen, CG, Sabin, M, Burgner, D, et al.
Attainment of Targets of the 20-Year Infancy-Onset Dietary Intervention and Blood Pressure Across Childhood and Young Adulthood: The Special Turku Coronary Risk Factor Intervention Project (STRIP)..
Hypertension
76(5)
:
1572 -1579
2020
view publication